A next-generation sequencing study on 21 cases of RDD did not reveal BRAF mutations, but a 33% incidence of mutually exclusive KRAS and MAP2K1 mutations, concluding on the occurrence of a MAPK pathway activation (71). The gene discussed is BRAF; the disease is sinus histiocytosis with massive lymphadenopathy.